Medical News |
- High-grade stenosis may be predictor for STEMI
- Switching clopidogrel to prasugrel has ‘unclear clinical utility’
- Surgery but not intensive therapy resolves diabetes in obese patients
- Retained cardiometabolic risk factors from childhood predict CVD, diabetes in adulthood
- Retained cardiometabolic risk factors from childhood predict CVD, diabetes in adulthood
- Malignant pleural mesothelioma best treated with pleurectomy/decortication
- Malignant pleural mesothelioma best treated with pleurectomy/decortication
- <i>CARD14</i> gene mutations linked to psoriasis
- Structural brain abnormalities in people at high risk for schizophrenia
- Thrombosis rates lowest with cobalt-chromium everolimus eluting stents
- Paired upregulation of <i>Notch2, Six1</i> contributes to adenocarcinoma progression
- Paired upregulation of <i>Notch2, Six1</i> contributes to adenocarcinoma progression
- CT screening fails to improve lung cancer mortality
- CT screening fails to improve lung cancer mortality
- Pemetrexed maintenance extends survival in advanced NSCLC
- Pemetrexed maintenance extends survival in advanced NSCLC
- Non-small-cell cancer patients benefit from immunotherapy
- Non-small-cell cancer patients benefit from immunotherapy
| High-grade stenosis may be predictor for STEMI Posted: 19 Apr 2012 05:00 PM PDT High-grade coronary stenosis may be an important predictor for ST-segment-elevation myocardial infarction, a study shows. |
| Switching clopidogrel to prasugrel has ‘unclear clinical utility’ Posted: 19 Apr 2012 05:00 PM PDT Researchers have found that switching from clopidogrel to prasugrel in patients with high on-treatment platelet reactivity induces platelet inhibition. |
| Surgery but not intensive therapy resolves diabetes in obese patients Posted: 19 Apr 2012 05:00 PM PDT Laparoscopic sleeve gastrectomy is more effective than intensive medical therapy for the treatment of Type 2 diabetes in morbidly obese patients, suggest study findings. |
| Retained cardiometabolic risk factors from childhood predict CVD, diabetes in adulthood Posted: 19 Apr 2012 05:00 PM PDT Risk factors for cardiovascular disease and Type 2 diabetes retained from childhood predict adult outcomes, report researchers. |
| Retained cardiometabolic risk factors from childhood predict CVD, diabetes in adulthood Posted: 19 Apr 2012 05:00 PM PDT Risk factors for cardiovascular disease and Type 2 diabetes retained from childhood predict adult outcomes, report researchers. |
| Malignant pleural mesothelioma best treated with pleurectomy/decortication Posted: 19 Apr 2012 05:00 PM PDT Study findings show that patients with malignant pleural mesothelioma derive greater benefit from a multi-modal treatment that includes pleurectomy/decortication than they do from one involving extrapleural pneumonectomy. |
| Malignant pleural mesothelioma best treated with pleurectomy/decortication Posted: 19 Apr 2012 05:00 PM PDT Study findings show that patients with malignant pleural mesothelioma derive greater benefit from a multi-modal treatment that includes pleurectomy/decortication than they do from one involving extrapleural pneumonectomy. |
| <i>CARD14</i> gene mutations linked to psoriasis Posted: 19 Apr 2012 05:00 PM PDT Mutations in the caspase recruitment domain 14 gene are associated with plaque and pustular psoriasis and psoriatic arthritis, show findings from two studies published in the American Journal of Human Genetics. |
| Structural brain abnormalities in people at high risk for schizophrenia Posted: 19 Apr 2012 05:00 PM PDT Individuals at high genetic risk for schizophrenia exhibit structural abnormalities in brain regions associated with language processing, research shows. |
| Thrombosis rates lowest with cobalt-chromium everolimus eluting stents Posted: 19 Apr 2012 05:00 PM PDT Definite stent thrombosis is less common with cobalt-chromium everolimus eluting stents than with bare-metal stents and other first- and second-generation drug-eluting stents, researchers report. |
| Paired upregulation of <i>Notch2, Six1</i> contributes to adenocarcinoma progression Posted: 18 Apr 2012 05:00 PM PDT Study findings show that paired upregulation of the transcription factors Notch2 and Six1 contributes to the progression of adenocarcinoma from preinvasive to invasive subtypes. |
| Paired upregulation of <i>Notch2, Six1</i> contributes to adenocarcinoma progression Posted: 18 Apr 2012 05:00 PM PDT Study findings show that paired upregulation of the transcription factors Notch2 and Six1 contributes to the progression of adenocarcinoma from preinvasive to invasive subtypes. |
| CT screening fails to improve lung cancer mortality Posted: 17 Apr 2012 05:00 PM PDT Study findings suggest that low-dose computed tomography screening improves detection of early-stage lung cancer but without an associated disease stage shift or reduction in mortality. |
| CT screening fails to improve lung cancer mortality Posted: 17 Apr 2012 05:00 PM PDT Study findings suggest that low-dose computed tomography screening improves detection of early-stage lung cancer but without an associated disease stage shift or reduction in mortality. |
| Pemetrexed maintenance extends survival in advanced NSCLC Posted: 16 Apr 2012 05:00 PM PDT In patients with advanced non-small-cell lung cancer, continuation of pemetrexed after four cycles of induction pemetrexed–cisplatin improves progression-free survival relative to placebo and is well tolerated, research shows. |
| Pemetrexed maintenance extends survival in advanced NSCLC Posted: 16 Apr 2012 05:00 PM PDT In patients with advanced non-small-cell lung cancer, continuation of pemetrexed after four cycles of induction pemetrexed–cisplatin improves progression-free survival relative to placebo and is well tolerated, research shows. |
| Non-small-cell cancer patients benefit from immunotherapy Posted: 15 Apr 2012 05:00 PM PDT Patients with non-small-cell lung cancer treated with immunotherapy benefit from improvements in overall and progression-free survival and partial response, results of a meta-analysis show. |
| Non-small-cell cancer patients benefit from immunotherapy Posted: 15 Apr 2012 05:00 PM PDT Patients with non-small-cell lung cancer treated with immunotherapy benefit from improvements in overall and progression-free survival and partial response, results of a meta-analysis show. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment